Advertisement

Canada expected to receive 1.5M doses of AstraZeneca vaccine from U.S.

Click to play video: 'Canada advised to pause AstraZeneca COVID-19 shots for those under 55' Canada advised to pause AstraZeneca COVID-19 shots for those under 55
WATCH: Canada advised to pause AstraZeneca COVID-19 shots for those under 55 – Mar 29, 2021

The federal government is expecting around 1.5 million doses of the Oxford-AstraZeneca vaccine from the United States Tuesday.

The vaccines are expected to arrive by truck and represent the first to come from south of the border.

Read more: Why does AstraZeneca vaccine guidance keep changing? Experts weigh in

Provincial governments decide on their own how to use a vaccine, but Dr. Howard Njoo, Canada’s deputy chief medical officer of health, says all provinces and territories have agreed to suspend the use of the vaccine for those under 55, pending the results of further study.

The province’s are acting on an advisory committee’s concerns about a possible link between the shot and rare blood clots.

Click to play video: 'AstraZeneca COVID-19 vaccine pause an ‘abundance of caution,’ according to disease expert' AstraZeneca COVID-19 vaccine pause an ‘abundance of caution,’ according to disease expert
AstraZeneca COVID-19 vaccine pause an ‘abundance of caution,’ according to disease expert – Mar 29, 2021

Dr. Heather Morrison, P.E.I.’s chief medical officer of health, says the risk of developing a serious problem after being immunized is “very, very low.”

Story continues below advertisement

She says people who received the AstraZeneca vaccine should look for symptoms such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, sudden onset of severe or persistent headache or blurred vision and skin bruising elsewhere than the site of vaccination, developing four to 20 days after getting the shot.

Sponsored content